Skip to main content
BCYC
NASDAQ Life Sciences

Bicycle Therapeutics Narrows Q3 Loss to $10.5M as Bayer Revenue Lifts Top Line

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.85
Mkt Cap
$270.879M
52W Low
$3.33
52W High
$9.08
52W Position info
16% above low
Off High info
58% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

BCYC sits 16% above its 52-week low of $3.33.

Summary

Bicycle Therapeutics posted a Q3 net loss of $10.5 million, or $0.15 per share, versus a $59.1 million loss a year earlier. Collaboration revenue jumped to $34.1 million from $11.7 million, driven by recognizing all remaining revenue under the terminated Bayer agreement — a one-time boost, not recurring. R&D fell to $33.4 million from $58.4 million after the August 2025 and March 2026 workforce cuts, and G&A dropped to $14.1 million from $18.9 million. Cash stood at $469.9 million at September 30, down from $628.1 million at year-end 2025, still a substantial runway for a company this size. The FDA granted Orphan Drug Designation to nuzefatide in pancreatic cancer in September, and the company expects Duravelo-2 survival data and its first company-sponsored BT1702 radioligand trial in the second half of 2027.

At the time of this announcement, BCYC was trading at $3.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $270.9M. The 52-week trading range was $3.33 to $9.08. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

BCYC - Latest Insights

BCYC
Jul 30, 2026, 7:38 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.82
Real-time Price: $3.37 info
Change: -$0.450 (-12%) info
Market Cap: $235.876M info
BCYC
Jul 30, 2026, 7:10 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.82
Real-time Price: $3.37 info
Change: -$0.450 (-12%) info
Market Cap: $235.876M info
BCYC
May 21, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $4.40
Real-time Price: $3.37 info
Change: -$1.03 (-23%) info
Market Cap: $235.876M info
BCYC
May 21, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.40
Real-time Price: $3.37 info
Change: -$1.03 (-23%) info
Market Cap: $235.876M info
BCYC
Apr 30, 2026, 7:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.70
Real-time Price: $3.37 info
Change: -$1.33 (-28%) info
Market Cap: $235.876M info